Literature DB >> 7791079

Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys.

L L Howell1.   

Abstract

This study characterized the effects of caffeine (1.0-30.0 mg/kg) and nicotine (0.1-3.0 mg/kg) administered alone and in combination on ventilation in unanesthetized rhesus monkeys. In seated monkeys prepared with a head plethysmograph, ventilation was measured during exposure to air (normocapnia), CO2 (3%, 4% and 5%) mixed in air (hypercapnia), 10% O2 mixed in N2 (hypoxia) and 100% O2 (hyperoxia). Caffeine produced marked, dose-dependent increases in ventilation during conditions of normocapnia and hypercapnia. In contrast, acute administration of nicotine had less pronounced respiratory-stimulant effects during all conditions. The joint effects of caffeine and nicotine on ventilation generally did not differ from those obtained with caffeine alone. Chronic administration of nicotine (1.0 mg/kg/day) for 4 consecutive wk via osmotic pumps significantly decreased the half-life of caffeine but had little effect on ventilation or on sensitivity to the respiratory-stimulant effects of caffeine. Two primary metabolites of caffeine, theophylline and paraxanthine, were active as respiratory stimulants and were equipotent to caffeine, and the joint effects of caffeine and its metabolites were additive. The results indicate that caffeine and nicotine stimulate respiration through different pharmacological mechanisms, in contrast to caffeine and its metabolites which exhibit a similar pharmacological profile. Moreover, significant pharmacokinetic interactions may be obtained when caffeine and nicotine are coadministered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791079

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Development of a rhesus monkey lung geometry model and application to particle deposition in comparison to humans.

Authors:  Bahman Asgharian; Owen Price; Gene McClellan; Rick Corley; Daniel R Einstein; Richard E Jacob; Jack Harkema; Stephan A Carey; Edward Schelegle; Dallas Hyde; Julia S Kimbell; Frederick J Miller
Journal:  Inhal Toxicol       Date:  2012-11       Impact factor: 2.724

2.  Pharmacology of nicotinic receptors in preBötzinger complex that mediate modulation of respiratory pattern.

Authors:  Xuesi M Shao; Jack L Feldman
Journal:  J Neurophysiol       Date:  2002-10       Impact factor: 2.714

3.  The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys.

Authors:  Colin S Cunningham; Megan J Moerke; Lance R McMahon
Journal:  Behav Pharmacol       Date:  2014-08       Impact factor: 2.293

4.  Efficacy of caffeine and modafinil in counteracting sleep deprivation in the marmoset monkey.

Authors:  Sanneke A M van Vliet; Marjan J Jongsma; Raymond A P Vanwersch; Berend Olivier; Ingrid H C H M Philippens
Journal:  Psychopharmacology (Berl)       Date:  2007-12-05       Impact factor: 4.530

Review 5.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.